Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

Indian pharma companies are expanding in the US through acquisitions to navigate regulations, diversify portfolios, and ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Vishal Manchanda, Pharma Analyst at Systematix Group, stated that Sun Pharmaceutical stands to gain significantly from its recent acquisition of Checkpoint Therapeutics, as it provides access to the ...

Zydus Lifesciences is working to advance its position in the global pharmaceutical sector by increasing its focus on medical ...

Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

The country's top specialty generics company recently acquired US-based Checkpoint that will further its oncology portfolio ...

Shares of Sun Pharmaceutical Industries rose more than 3 per cent following ICICI Securities' upgrade of the stock to a 'Buy' ...

The brokerage firm Motilal Oswal had a ‘Buy call on three stocks on March 11. It has picked Sun Pharma after Checkpoint ...

Five things you need to know in local business news to start your workday, including how Monday's stock market rout shaved $21 billion off five Massachusetts companies, plus more MGB layoffs, a ...

Shareholder law firm Julie & Holleman LLP is investigating the proposed $4.10 per share sale of Checkpoint Therapeutics ...